SOL-MILLENNIUM Medical Group Competitors, Revenue, Alternatives and Pricing

Claim your profile


Chicago, IL USA
Total Funding:N/A
Industry:Medical Equip
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • SOL-MILLENNIUM Medical Group's estimated annual revenue is currently $26.1M per year.(?)
  • SOL-MILLENNIUM Medical Group's estimated revenue per employee is $251,000

Employee Data

  • SOL-MILLENNIUM Medical Group has 104 Employees.(?)
  • SOL-MILLENNIUM Medical Group grew their employee count by 24% last year.
  • SOL-MILLENNIUM Medical Group currently has 1 job openings.

SOL-MILLENNIUM Medical Group is a global healthcare company dedicated to the research and development, manufacture and distribution of high quality medical devices. \n\nOriginally a leading producer of plastic moulds for the global medical industry - we were the first syringe mould producer in China and now supply over 60% of China’s syringe mould needs, as well exporting globally.\n\nThis background sets the stage for our current focus in developing high quality and affordable safety medical devices that support best clinical practice – whilst also protecting healthcare workers (and their patients) from the risks associated with needlestick injury and accidental blood exposure.\n\nWe currently manufacture a range of safety syringes, needles and blood collection devices under the SOL-CARE and SOL-GUARD brands. We also produce syringes and needles for the veterinary industry under the SOL-VET line of products, as well as an extensive range of standard (non-safety) needles and syringes.\n\nWe have a rich pipeline of new product innovation, and ambitious plans to grow our brands and our business. \n\nClose collaboration with frontline healthcare professionals is critical to the way we work – by sharing knowledge and ideas together we continuously improve our offer and work toward our goal of ‘Building a Heathier Tomorrow’. \n \nSOL-MILLENNIUM has global presence with sales and marketing offices in Brazil, Poland and USA and a European R&D Centre, based in Switzerland.